516 related articles for article (PubMed ID: 10857214)
21. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
22. Are borderline tumors of the ovary safely treated by laparoscopy?
Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
[TBL] [Abstract][Full Text] [Related]
23. [Clinical and pathological features of borderline ovarian tumors].
Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693
[TBL] [Abstract][Full Text] [Related]
24. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases.
Lim-Tan SK; Cajigas HE; Scully RE
Obstet Gynecol; 1988 Nov; 72(5):775-81. PubMed ID: 3173929
[TBL] [Abstract][Full Text] [Related]
25. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
27. Pseudomyxoma peritonei: a review of 23 cases.
Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
Provenza C; Young RH; Prat J
Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
[TBL] [Abstract][Full Text] [Related]
29. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
BJOG; 2009 May; 116(6):860-2. PubMed ID: 19432576
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
[TBL] [Abstract][Full Text] [Related]
31. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
32. Conservative treatment of borderline ovarian tumors.
Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
[TBL] [Abstract][Full Text] [Related]
33. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
[TBL] [Abstract][Full Text] [Related]
35. [Borderline tumors of the ovary: a multicenter study in 137 patients].
Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
[TBL] [Abstract][Full Text] [Related]
36. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
37. Management of borderline tumors of the ovary: state of the art.
Tropé C; Kaern J
Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
[TBL] [Abstract][Full Text] [Related]
38. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics].
Kindermann G; Maassen V; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588
[TBL] [Abstract][Full Text] [Related]
39. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM
Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764
[TBL] [Abstract][Full Text] [Related]
40. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]